SectorBiological Technology
Established Date15/06/2021
Listing Date09/02/2024
ExchangeNASDAQ Stock Exchange
Full-time Employees92
Fiscal Year Ends31/12
Security TypeCommon stock
Office address256 E. Grand Avenue, Suite 104, South San Francisco, CA 94080
Business
IntroductionBridgeBio Oncology Therapeutics, Inc., was incorporated as a Cayman Islands exempted company on June 15, 2021. Effective August 12, 2025, the Company completed the previously announced Business Combination, with the combined company's place of incorporation in Delaware. BBOT is a clinical-stage biotechnology company whose mission is to transform the lives of cancer patients driven by the two most commonly mutated oncogenes, RAS and PI3Kα.
